Phase II study of pembrolizumab in refractory esophageal cancer with correlates of response and survival

Phase II study of pembrolizumab in refractory esophageal cancer with correlates of response and survival

Saved in:
Bibliographic Details
Main Authors: Hui Zheng, Eirini Pectasides, Mohamed Uduman, Charles S Fuchs, James M Cleary, Adam J Bass, Jérémy Augustin, Leonie K de Klerk, Anuj K Patel, Sarah Derks, Nihal Raman, Fahire G Akarca, Nadine J McCleary, Douglas A Rubinson, Jeffrey W Clark, Bridget Fitzpatrick, Lauren K Brais, Megan E Cavanaugh, Amanda J Rode, Melissa G Jean, Patrick H Lizotte, Matthew J Nazzaro, Peter C Enzinger
Format: article
Language:EN
Published: BMJ Publishing Group 2021
Subjects:
Neoplasms. Tumors. Oncology. Including cancer and carcinogens
RC254-282
Online Access:https://doaj.org/article/88b5dffda1124385a9d172a7073bce20
Tags: Add Tag
No Tags, Be the first to tag this record!

Internet

https://doaj.org/article/88b5dffda1124385a9d172a7073bce20

Similar Items